MENU

Support

Mobile Trading App

PC Trading App

Web Trading Platform

Download

forex cross rate

MarketsForex

  • Price
  • Ideas
  • Signal
  • Chart
  • Cross Rate
  • Heat Map
  • About Market

MarketsForex

PriceIdeasSignalChartCross RateHeat MapAbout Market
Forex Cross Rate

Forex cross rates provide investors with the latest news and introduction of exchange rates, as well as cross exchange rate tables.Investors can know the foreign exchange cross rates between dozens of currencies on the page of "Forex Cross Rate", most of which are the most popular currencies in the world, such as euro, U.S. dollar, Japanese yen, British pound, Swiss franc, Australian dollar, Canadian dollar, and New Zealand dollar. At the same time, investors will also get free access to the latest news and economic calendars of various currencies on the page of "Forex Cross Rate".

Track all markets on TradingView

Past performance is not an indication of future results.

NewsEconomic Calendar

Novo Nordisk (NVO.N) CEO: We are very confident that we can meet the demand for weight loss drug Wegovy in the United States.

News Flash04-02 07:39From XTrend Speed
Novo Nordisk (NVO.N) CEO: We are very confident that we can meet the demand for weight loss drug Wegovy in the United States.

Novo Nordisk (NVO.N) CEO: 2026 will be the year we face pricing headwinds in the U.S., including from the most-favored-nation policy.

News Flash04-02 07:34From XTrend Speed
Novo Nordisk (NVO.N) CEO: 2026 will be the year we face pricing headwinds in the U.S., including from the most-favored-nation policy.

Novo Nordisk (NVO.N) CEO: Hopes that Medicare coverage of obesity drugs agreed with U.S. President Trump's administration will start "around the middle of the year" this year.

News Flash04-02 07:27From XTrend Speed
Novo Nordisk (NVO.N) CEO: Hopes that Medicare coverage of obesity drugs agreed with U.S. President Trump's administration will start "around the middle of the year" this year.

Novartis (NVS.N) CEO: Any changes in European drug pricing are "premature" in the context of most-favored nation status.

News Flash04-02 07:01From XTrend Speed
Novartis (NVS.N) CEO: Any changes in European drug pricing are "premature" in the context of most-favored nation status.

Indian regulators have proposed relaxing the eligibility criteria for entities to act as brokers.

News Flash04-02 06:56From XTrend Speed
Indian regulators have proposed relaxing the eligibility criteria for entities to act as brokers.

Novartis (NVS.N) CEO: U.S. most-favored-nation rules will have no material impact on our 2026 guidance.

News Flash04-02 06:49From XTrend Speed
Novartis (NVS.N) CEO: U.S. most-favored-nation rules will have no material impact on our 2026 guidance.